Dexamfetamine shortage — NZ supply status & alternatives

Dexamfetamine

ATC N06BA02

🇦🇺 AUST R 19684 · Aspen Pharmacare Australia Pty Ltd

In supply · Australia

Noumed

In supply · 🇦🇺 Australia · short in🇳🇿 NZ🇳🇱 NL

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$5.95DPMQ A$26.30details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)

Brand names	Noumed

ATC level 5	N06BA02

ATC level 4	N06BA

Therapeutic category	Auto-created by Pharmac — New Zealand Medicine Supply Disruptions scraper

Controlled substance	No

Marketing-authorisation holders	Aspen Pharmacare Australia Pty Ltd, Garden House Australia, THORNTON & ROSS LIMITED, TEVA UK LIMITED +3 more

Registrations on file	30

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$5.95

AEMP

Dispensed (DPMQ)

A$26.30

incl. fees

Pack

dexamfetamine sulfate 5 mg tablet, 100

Source: PBSEffective July 2026 · AUD

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇳🇿

New Zealand

Pharmac · 14h ago

High

🇳🇱

Netherlands

CBG-MEB · 13h ago

Medium

Verified timeline regulator events

🇳🇱 30 June 2026

medium reported

🇳🇿 24 June 2026

high reported

🇳🇱 24 Apr 2026

medium reported

🇳🇿 16 Apr 2026

high reported

🇳🇿 20 Mar 2026

high reported

Sources official regulators

🇳🇱

CBG-MEB

verified 13h ago

verify ↗

🇳🇿

Pharmac

verified 14h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders30 registrations · 7 MA holders

Product	Strength	Form	Market	MA holder	Status
ASPEN DEXAMFETAMINE dexamfetamine sulfate	5mg	—	🇦🇺 AU	Aspen Pharmacare Australia Pty Ltd	Active
ACTAVANZ lisdexamfetamine dimesilate	40 mg	—	🇦🇺 AU	Garden House Australia	Active
ACTAVANZ lisdexamfetamine dimesilate	30 mg	—	🇦🇺 AU	Garden House Australia	Active
ACTAVANZ lisdexamfetamine dimesilate	70 mg	—	🇦🇺 AU	Garden House Australia	Active
ACTAVANZ lisdexamfetamine dimesilate	50 mg	—	🇦🇺 AU	Garden House Australia	Active
ACTAVANZ lisdexamfetamine dimesilate	60 mg	—	🇦🇺 AU	Garden House Australia	Active
ACTAVANZ lisdexamfetamine dimesilate	20 mg	—	🇦🇺 AU	Garden House Australia	Active
Lisdexamfetamine Dimesylate	20MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Lisdexamfetamine Dimesylate	30MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Lisdexamfetamine Dimesylate	40MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Lisdexamfetamine Dimesylate	50MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Lisdexamfetamine Dimesylate	60MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Lisdexamfetamine Dimesylate	70MG	capsule	🇬🇧 GB	THORNTON & ROSS LIMITED	Active
Dexamfetamine Sulfate	5MG	tablet	🇬🇧 GB	TEVA UK LIMITED	Active
Lisdexamfetamine Dimesylate	20 MG	capsule	🇬🇧 GB	TEVA UK LIMITED	Active

+15 more registrations on file

Mederti Drug Report

Generated 2 July 2026 · Australia market · 2 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.